On a roll, UCB picks up another rare disease FDA approval
4th November 2025 Uncategorised 0UCB has scored an FDA approval for ultra-rare disease treatment Kygevvi, continuing the positive momentum for the Belgian company, which has scored three nods in the U.S. for rare disease treatments in less than three years.
More: On a roll, UCB picks up another rare disease FDA approval
Source: fierce